European stocks trading in the US mostly rose late Tuesday morning, pushing the S&P Europe Select ADR Index up 0.82% to 1,901.23. The advance was led by a handful of biotech names, while energy stocks moved in the opposite direction.
American depositary receipts (ADRs) are shares of foreign companies that trade on US exchanges, allowing investors to buy European companies without dealing with foreign currencies or markets. The S&P Europe Select ADR Index tracks a basket of these, giving a snapshot of how European equities are faring in US trading.
Biotech leads, energy lags
Biotech ADRs posted the biggest jumps. Evaxion rose 9.9%, argenx gained 6.3%, and DBV Technologies climbed 6.7%. These are large moves for a single session, and because biotech stocks often swing more than steadier sectors, they can have an outsized impact on the index.
Energy stocks, by contrast, moved lower but by smaller amounts. Equinor fell 2.5%, while BP and Eni slipped between 1% and 2%. That divergence meant the index finished higher, but the headline move masked a split session.
Biotech's strength comes as investors continue to watch for catalysts like clinical trial results and regulatory decisions. A recent note from Bank of America warned that the biotech rally could be losing steam as such catalysts dry up, but Tuesday's moves suggest some names still have momentum. For context, see our earlier coverage of biotech rally losing steam.
What this means for investors
For everyday investors, the takeaway is that a rising index doesn't always mean broad strength. Tuesday's session was a reminder that sector-specific moves can drive the overall number, and that biotech's volatility can skew the picture.
If you hold European ADRs, it's worth noting that biotech's gains were not matched by energy. That divergence could reflect different drivers: biotech may be reacting to company-specific news, while energy could be responding to oil price movements or broader economic concerns. For instance, Ryanair has warned that oil and taxes could push airfares up, which highlights how energy costs ripple through the economy.
Investors should also keep an eye on the broader European market. Recent sessions have seen jitters over French political unrest and bank probes, as noted in our coverage of European shares slipping. While Tuesday's ADR move was positive, it doesn't erase those underlying concerns.
Looking ahead
As Europe's earnings season gets underway, analysts have been lifting profit forecasts, which could provide support for European stocks. Our earlier report on analysts lifting profit forecasts suggests optimism is building.
But with biotech leading gains, investors should watch whether that sector can sustain its momentum or if the rally fades as catalysts pass. Energy stocks, meanwhile, may continue to be pressured by oil price dynamics. The split in Tuesday's session is a useful reminder that diversification matters—what helps one sector can hurt another.
For now, the S&P Europe Select ADR Index sits higher, but the real story is the divergence beneath the surface. As always, it's wise to look beyond the headline number and understand what's driving the move.
